MLNT

MELINTA THERAPEUTICS, INC. /NEW/CIK 1461993 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for MLNT PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for MLNT

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
JOHNSON JOHN	Interim CEO	8	$0	$72.4K	2019-06-27
Galeota James JR	Director	3	$0	$0	2019-06-11
ZACCARDELLI DAVID	Director	4	$200.0K	$0	2019-06-11
Koestler Thomas P	Director	3	$0	$0	2019-06-11
Ferro Kevin	Director, 10% Owner	3	$0	$0	2019-06-11
DOWNEY BRUCE	Director	2	$0	$0	2019-06-11
GILL DAVID N	Director	4	$30.4K	$0	2019-06-11
Cammarata Sue	Chief Medical Officer	3	$20.0K	$0	2019-05-16
Milligan Peter J	Chief Financial Officer	2	$0	$0	2019-05-16
Vatera Healthcare Partners LLC	Director, 10% Owner	1	$75.00M	$0	2019-02-22
Duffy Erin	Chief Scientific Officer	2	$20.0K	$0	2018-06-12
Estrem Paul	Chief Financial Officer	2	$50.0K	$0	2018-06-12
Wechsler Daniel Mark	See Remarks	4	$250.0K	$0	2018-06-12
GONZALO CECILIA	Director	2	$0	$0	2018-06-12
Kong Garheng	Director	2	$0	$0	2018-06-12
VATERA HOLDINGS LLC	Director, 10% Owner	6	$194.29M	$0	2018-05-29

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
JOHNSON JOHN	Chief Executive Officer	S Sale	2019-06-27	2019-07-02	13,000	$5.57	$72.4K	37,400	SEC↗
Galeota James JR	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
Koestler Thomas P	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
ZACCARDELLI DAVID	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
GILL DAVID N	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
DOWNEY BRUCE	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
Ferro Kevin	Director, 10% Owner	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
JOHNSON JOHN	Director	M Exercise deriv	2019-05-22	2019-06-26	50,000	—	$0	350,000	SEC↗
JOHNSON JOHN	Director	M Exercise	2019-05-22	2019-06-26	50,000	—	$0	50,400	SEC↗
Milligan Peter J	Chief Financial Officer	A Award deriv	2019-05-16	2019-05-20	150,000	—	$0	150,000	SEC↗
Cammarata Sue	Chief Medical Officer	A Award deriv	2019-05-16	2019-05-20	120,000	—	$0	120,000	SEC↗
Vatera Healthcare Partners LLC	Director, 10% Owner	P Buy deriv	2019-02-22	2019-02-26	9,375,000	$8.00	$75.00M	9,375,000	SEC↗
JOHNSON JOHN	Chief Executive Officer	A Award deriv	2019-02-22	2019-02-26	400,000	—	$0	400,000	SEC↗
DOWNEY BRUCE	Director	A Award deriv	2018-11-30	2018-12-03	25,000	—	$0	25,000	SEC↗
JOHNSON JOHN	Interim CEO	A Award deriv	2018-10-26	2018-10-29	150,000	—	$0	150,000	SEC↗
JOHNSON JOHN	Interim CEO	A Award deriv	2018-10-26	2018-10-29	50,000	—	$0	50,000	SEC↗
Milligan Peter J	Chief Financial Officer	A Award deriv	2018-09-21	2018-09-25	370,000	—	$0	370,000	SEC↗
Wechsler Daniel Mark	See Remarks	A Award deriv	2018-06-12	2018-06-14	150,000	—	$0	150,000	SEC↗
Estrem Paul	Chief Financial Officer	A Award deriv	2018-06-12	2018-06-14	76,000	—	$0	76,000	SEC↗
Duffy Erin	Chief Scientific Officer	A Award deriv	2018-06-12	2018-06-14	38,000	—	$0	38,000	SEC↗
Galeota James JR	Director	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
Galeota James JR	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Cammarata Sue	Chief Medical Officer	A Award deriv	2018-06-12	2018-06-14	80,000	—	$0	80,000	SEC↗
Kong Garheng	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Kong Garheng	Director	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
GILL DAVID N	Director	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
GILL DAVID N	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Ferro Kevin	Director, 10% Owner	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
Ferro Kevin	Director, 10% Owner	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
ZACCARDELLI DAVID	Director	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
ZACCARDELLI DAVID	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
GONZALO CECILIA	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
GONZALO CECILIA	Director	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
JOHNSON JOHN	Director	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
JOHNSON JOHN	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Koestler Thomas P	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Koestler Thomas P	Director	A Award deriv	2018-06-12	2018-06-14	9,100	—	$0	9,100	SEC↗
Cammarata Sue	Chief Medical Officer	P Buy	2018-05-29	2018-05-31	4,000	$5.00	$20.0K	4,000	SEC↗
VATERA HOLDINGS LLC	Director, 10% Owner	P Buy	2018-05-29	2018-05-31	7,878,500	$5.00	$39.39M	16,607,959	SEC↗
VATERA HOLDINGS LLC	Director, 10% Owner	P Buy	2018-05-29	2018-05-31	7,500,000	$5.00	$37.50M	16,007,237	SEC↗
VATERA HOLDINGS LLC	Director, 10% Owner	P Buy	2018-05-29	2018-05-31	7,878,500	$5.00	$39.39M	16,607,959	SEC↗
Wechsler Daniel Mark	See Remarks	P Buy	2018-05-29	2018-05-31	50,000	$5.00	$250.0K	50,000	SEC↗
Duffy Erin	Chief Scientific Officer	P Buy	2018-05-29	2018-05-31	4,000	$5.00	$20.0K	4,000	SEC↗
ZACCARDELLI DAVID	Director	P Buy	2018-05-29	2018-05-31	40,000	$5.00	$200.0K	46,500	SEC↗
Estrem Paul	Chief Financial Officer	P Buy	2018-05-29	2018-05-31	10,000	$5.00	$50.0K	10,000	SEC↗
GILL DAVID N	Director	P Buy	2018-05-25	2018-05-30	5,000	$6.09	$30.4K	6,000	SEC↗
VATERA HOLDINGS LLC	Director, 10% Owner	P Buy	2018-01-05	2018-01-09	1,777,778	$13.50	$24.00M	8,507,237	SEC↗
VATERA HOLDINGS LLC	Director, 10% Owner	P Buy	2018-01-05	2018-01-09	2,000,000	$13.50	$27.00M	8,729,459	SEC↗
VATERA HOLDINGS LLC	Director, 10% Owner	P Buy	2018-01-05	2018-01-09	2,000,000	$13.50	$27.00M	8,729,459	SEC↗
Wechsler Daniel Mark	President and CEO	A Award deriv	2017-11-03	2017-11-07	183,661	—	$0	183,661	SEC↗
Wechsler Daniel Mark	President and CEO	A Award deriv	2017-11-03	2017-11-07	550,981	—	$0	550,981	SEC↗